Imran S. Khan
University of California, San Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Imran S. Khan.
Journal of Experimental Medicine | 2014
Imran S. Khan; Maria L. Mouchess; Meng Lei Zhu; Bridget Conley; Kayla J. Fasano; Yafei Hou; Lawrence Fong; Maureen A. Su; Mark S. Anderson
Modulation of central tolerance through RANKL alters thymic output and enhances anti-tumor immunity.
Cell Reports | 2013
Todd Metzger; Imran S. Khan; James M. Gardner; Maria L. Mouchess; Kellsey Johannes; Anna K. Krawisz; Katarzyna M. Skrzypczynska; Mark S. Anderson
Thymic epithelial cells in the medulla (mTECs) play a critical role in enforcing central tolerance through expression and presentation of tissue-specific antigens (TSAs) and deletion of autoreactive thymocytes. TSA expression requires autoimmune regulator (Aire), a transcriptional activator present in a subset of mTECs characterized by high CD80 and major histocompatibility complex II expression and a lack of potential for differentiation or proliferation. Here, using an Aire-DTR transgenic line, we show that short-term ablation specifically targets Aire(+) mTECs, which quickly undergo RANK-dependent recovery. Repeated ablation also affects Aire(-) mTECs, and using an inducible Aire-Cre fate-mapping system, we find that this results from the loss of a subset of mTECs that showed prior expression of Aire, maintains intermediate TSA expression, and preferentially migrates toward the center of the medulla. These results clearly identify a distinct stage of mTEC development and underscore the diversity of mTECs that play a key role in maintaining tolerance.
Nature Immunology | 2014
Michael Waterfield; Imran S. Khan; Jessica T Cortez; Una Fan; Todd Metzger; Alexandra Greer; Kayla J. Fasano; Marc Martinez-Llordella; Joshua L. Pollack; David J. Erle; Maureen Su; Mark S. Anderson
The maintenance of immunological tolerance requires the deletion of self-reactive T cells in the thymus. The expression of genes encoding tissue-specific antigens (TSAs) by thymic epithelial cells is critical for this process and depends on activity of the transcriptional regulator Aire; however, the molecular mechanisms Aire uses to target loci encoding TSAs are unknown. Here we identified two Aire-interacting proteins known to be involved in gene repression, ATF7ip and MBD1, that were required for Aires targeting of loci encoding TSAs. Moreover, Mbd1−/− mice developed pathological autoimmunity and had a defect in Aire-dependent thymic expression of genes encoding TSAs, which underscores the importance of Aires interaction with the ATF7ip-MBD1 protein complex in maintaining central tolerance.
European Journal of Immunology | 2014
Imran S. Khan; Ruth Taniguchi; Kayla J. Fasano; Mark S. Anderson; Lukas T. Jeker
Medullary thymic epithelial cells (mTECs) facilitate the deletion of developing self‐reactive T cells by displaying a diverse repertoire of tissue‐specific antigens, a process which largely depends on the expression of the autoimmune regulator (Aire) gene. Mature microRNAs (miRNAs) that regulate gene expression post‐transcriptionally are generated in a multistep process. The microprocessor complex, including DGCR8, cleaves canonical miRNAs, but alternative DGCR8‐independent miRNA biogenesis pathways exist as well. In order to study the role of canonical miRNAs in thymic epithelial cells (TECs), we ablated Dgcr8 using a FoxN1‐Cre transgene. We report that DGCR8‐deficient TECs are unable to maintain proper thymic architecture and exhibit a dramatic loss of thymic cellularity. Importantly, DGCR8‐deficient TECs develop a severe loss of Aire+ mTECs. Using a novel immunization approach to amplify and detect self‐reactive T cells within a polyclonal TCR repertoire, we demonstrate a link between the loss of Aire expression in DGCR8‐deficient TECs and the breakdown of negative selection in the thymus. Thus, DGCR8 and canonical miRNAs are important in TECs for supporting central tolerance.
Science Translational Medicine | 2015
Nils Landegren; Donald Sharon; Anthony K. Shum; Imran S. Khan; Kayla J. Fasano; Åsa Hallgren; Caroline Kampf; Eva Freyhult; Brita Ardesjö-Lundgren; Mohammad Alimohammadi; Sandra Rathsman; Jonas F. Ludvigsson; Dan Lundh; Ruben D. Motrich; Virginia E. Rivero; Lawrence Fong; Aleksander Giwercman; Jan Gustafsson; Jaakko Perheentupa; Eystein S. Husebye; Mark S. Anderson; Michael Snyder; Olle Kämpe
TGM4 is a male-specific autoantigen for prostatitis associated with autoimmune polyendocrine syndrome type 1. AIREing out autoimmunity Patients with autoimmune polyendocrine syndrome type 1(APS1) experience dysfunction in multiple endocrine glands due to mutations in the AIRE gene, which helps promote immune tolerance. These patients frequently are infertile; female infertility can be explained by autoimmune ovarian failure, but the causes of male infertility have remained unclear. Now, Landegren et al. report that the prostatic secretory molecule tranglutaminase 4 (TGM4) is a male-specific autoantigen in APS1 patients that could contribute to subfertility. They found autoantibodies to TGM4 in APS1 patients beginning at puberty, and confirmed in AIRE-deficient mice that TGM4 autoantibodies lead to a destructive prostatitis. These data could help explain infertility in male APS1 patients. Autoimmune polyendocrine syndrome type 1 (APS1), a monogenic disorder caused by AIRE gene mutations, features multiple autoimmune disease components. Infertility is common in both males and females with APS1. Although female infertility can be explained by autoimmune ovarian failure, the mechanisms underlying male infertility have remained poorly understood. We performed a proteome-wide autoantibody screen in APS1 patient sera to assess the autoimmune response against the male reproductive organs. By screening human protein arrays with male and female patient sera and by selecting for gender-imbalanced autoantibody signals, we identified transglutaminase 4 (TGM4) as a male-specific autoantigen. Notably, TGM4 is a prostatic secretory molecule with critical role in male reproduction. TGM4 autoantibodies were detected in most of the adult male APS1 patients but were absent in all the young males. Consecutive serum samples further revealed that TGM4 autoantibodies first presented during pubertal age and subsequent to prostate maturation. We assessed the animal model for APS1, the Aire-deficient mouse, and found spontaneous development of TGM4 autoantibodies specifically in males. Aire-deficient mice failed to present TGM4 in the thymus, consistent with a defect in central tolerance for TGM4. In the mouse, we further link TGM4 immunity with a destructive prostatitis and compromised secretion of TGM4. Collectively, our findings in APS1 patients and Aire-deficient mice reveal prostate autoimmunity as a major manifestation of APS1 with potential role in male subfertility.
PLOS ONE | 2015
Imran S. Khan; Chong Y. Park; Anastasia Mavropoulos; Nikki Shariat; Joshua L. Pollack; Andrea J. Barczak; David J. Erle; Michael T. McManus; Mark S. Anderson; Lukas T. Jeker
Thymic epithelial cells (TECs) support T cell development in the thymus. Cortical thymic epithelial cells (cTECs) facilitate positive selection of developing thymocytes whereas medullary thymic epithelial cells (mTECs) facilitate the deletion of self-reactive thymocytes in order to prevent autoimmunity. The mTEC compartment is highly dynamic with continuous maturation and turnover, but the genetic regulation of these processes remains poorly understood. MicroRNAs (miRNAs) are important regulators of TEC genetic programs since miRNA-deficient TECs are severely defective. However, the individual miRNAs important for TEC maintenance and function and their mechanisms of action remain unknown. Here, we demonstrate that miR-205 is highly and preferentially expressed in mTECs during both thymic ontogeny and in the postnatal thymus. This distinct expression is suggestive of functional importance for TEC biology. Genetic ablation of miR-205 in TECs, however, neither revealed a role for miR-205 in TEC function during homeostatic conditions nor during recovery from thymic stress conditions. Thus, despite its distinct expression, miR-205 on its own is largely dispensable for mTEC biology.
Nature | 2018
Corey N. Miller; Irina Proekt; Jakob von Moltke; Kristen L. Wells; Aparna R. Rajpurkar; Haiguang Wang; Kristin Rattay; Imran S. Khan; Todd Metzger; Joshua L. Pollack; Adam Fries; Wint Lwin; Eric J. Wigton; Audrey Parent; Bruno Kyewski; David J. Erle; Kristin A. Hogquist; Lars M. Steinmetz; Richard M. Locksley; Mark S. Anderson
The thymus is responsible for generating a diverse yet self-tolerant pool of T cells1. Although the thymic medulla consists mostly of developing and mature AIRE+ epithelial cells, recent evidence has suggested that there is far greater heterogeneity among medullary thymic epithelial cells than was previously thought2. Here we describe in detail an epithelial subset that is remarkably similar to peripheral tuft cells that are found at mucosal barriers3. Similar to the periphery, thymic tuft cells express the canonical taste transduction pathway and IL-25. However, they are unique in their spatial association with cornified aggregates, ability to present antigens and expression of a broad diversity of taste receptors. Some thymic tuft cells pass through an Aire-expressing stage and depend on a known AIRE-binding partner, HIPK2, for their development. Notably, the taste chemosensory protein TRPM5 is required for their thymic function through which they support the development and polarization of thymic invariant natural killer T cells and act to establish a medullary microenvironment that is enriched in the type 2 cytokine, IL-4. These findings indicate that there is a compartmentalized medullary environment in which differentiation of a minor and highly specialized epithelial subset has a non-redundant role in shaping thymic function.A comprehensive analysis of the thymic medulla identifies a tuft-cell-like thymic epithelial cell population that is necessary for shaping thymic function.
Cell Stem Cell | 2013
Audrey Parent; Holger A. Russ; Imran S. Khan; Taylor N. LaFlam; Todd Metzger; Mark S. Anderson; Matthias Hebrok
JCI insight | 2017
Pearl Bakhru; Meng-Lei Zhu; Hsing-Hui Wang; Lee K. Hong; Imran S. Khan; Maria L. Mouchess; Ajay S. Gulati; Joshua Starmer; Yafei Hou; David Sailer; Sandra J. Lee; Fengmin Zhao; John M. Kirkwood; Stergios J. Moschos; Lawrence Fong; Mark S. Anderson; Maureen A. Su
Nature Immunology | 2014
Michael Waterfield; Imran S. Khan; Jessica T Cortez; Una Fan; Todd Metzger; Alexandra Greer; Kayla J. Fasano; Marc Martinez-Llordella; Joshua L. Pollack; David J. Erle; Maureen Su; Mark S. Anderson